Objective Both belimumab and telitacicept are recognised blockers for B lymphocyte activation, both of which have been ...

Two anti-transferrin receptor (TfR) nanobodies, V H H123 specific for mouse TfR and V H H188 specific for human TfR (huTfR) were used to track transplants non-invasively by PET/CT in mouse models, ...